诚意药业：公司盐酸多巴酚丁胺注射液通过仿制药一致性评价

Core Viewpoint - Chengyi Pharmaceutical has received approval from the National Medical Products Administration for its hydrochloride dobutamine injection, which has passed the consistency evaluation of generic drug quality and efficacy [1] Group 1: Product Approval - The hydrochloride dobutamine injection is primarily used for heart failure caused by decreased myocardial contractility in organic heart disease [1] - It is indicated for short-term supportive treatment, including cases of low cardiac output syndrome following cardiac surgery [1]